These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 1419291

  • 1. A phase II study of 5-fluorouracil and high-dose folinic acid in combination with cyclophosphamide and mitoxantrone for advanced breast cancer.
    Aitini E, Cavazzini G, Cantore M, Rabbi C, Rivera A, Togliani B, Di Marco A, Smerieri F.
    Eur J Cancer; 1992; 28A(12):1968-70. PubMed ID: 1419291
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
    Greco FA, Hainsworth JD.
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer.
    Jones SE, Mennel RG, Brooks B, Westrick MA, Allison MA, Paulson RS, Tilmann K, Rea B.
    J Clin Oncol; 1991 Oct; 9(10):1736-9. PubMed ID: 1919625
    [Abstract] [Full Text] [Related]

  • 4. Mitoxantrone, folinic acid, 5-fluorouracil and prednisone as first-line chemotherapy for advanced breast carcinoma. A phase II study.
    Carmo-Pereira J, Costa FO, Henriques E.
    Eur J Cancer; 1993 Oct; 29A(13):1814-6. PubMed ID: 8260231
    [Abstract] [Full Text] [Related]

  • 5. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD, Jolivet J, Birch R, Hopkins LG, Greco FA.
    Cancer; 1997 Feb 15; 79(4):740-8. PubMed ID: 9024712
    [Abstract] [Full Text] [Related]

  • 6. Folinic acid, 5-fluorouracil bolus and infusion and mitoxantrone with or without cyclophosphamide in metastatic breast cancer.
    Louvet C, de Gramont A, Demuynck B, Beerblock K, Varette C, Soubrane D, Marpeau L, Pigné A, Guillot T, Krulik M.
    Eur J Cancer; 1993 Feb 15; 29A(13):1835-8. PubMed ID: 8260236
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer.
    Martoni A, Rani P, Ercolino L, Canova N, Pannuti F.
    Chemioterapia; 1988 Oct 15; 7(5):345-9. PubMed ID: 3224403
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.
    Hainsworth JD, Jones SE, Mennel RG, Blum JL, Greco FA.
    J Clin Oncol; 1996 May 15; 14(5):1611-6. PubMed ID: 8622079
    [Abstract] [Full Text] [Related]

  • 10. Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancer.
    Lorusso V, Mancarella S, Catino A, Brandi M, Paradiso A, Latorre A, Mastria A, De Mitrio A, Guida M, De Lena M.
    Tumori; 1999 May 15; 85(1):60-4. PubMed ID: 10228500
    [Abstract] [Full Text] [Related]

  • 11. A phase II trial of mitoxantrone plus cyclophosphamide and 5-fluorouracil in modulation with levo-folinate for advanced breast cancer patients.
    Leonardi V, Meli M, Palmeri S, Russo A, Rini GB, Peralta S, Rausa L.
    J Chemother; 1995 Apr 15; 7(2):160-6. PubMed ID: 7545224
    [Abstract] [Full Text] [Related]

  • 12. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity.
    Yen CC, Tung SL, Hsieh RK, Chiou TJ, Liu JH, Wang WS, Chen PM.
    Jpn J Clin Oncol; 1997 Oct 15; 27(5):316-20. PubMed ID: 9390208
    [Abstract] [Full Text] [Related]

  • 13. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U, Wilke H, Pari CP, Strumberg D, Harstrick A, Eberhardt W, Becher R, Diergarten K, Seeber S.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
    Merlini L, Secondo V, Mammoliti S, Bellotti P, Castello C, Gallo L.
    Anticancer Res; 1994 Dec 15; 14(3B):1423-6. PubMed ID: 8067717
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 16. Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
    Samonigg H, Stöger H, Kasparek AK, Schmid M, Dusleag J, Pfeiffer K, Smola M, Steindorfer P, Lechner P.
    Cancer Chemother Pharmacol; 1991 Oct 15; 27(6):477-80. PubMed ID: 2013118
    [Abstract] [Full Text] [Related]

  • 17. Mitoxantrone, fluorouracil plus L-leucovorin, and vinorelbine in pretreated advanced breast cancer.
    Colleoni M, Nelli P, Gaion F, Sgarbossa G, Manente P.
    Oncology; 1995 Oct 15; 52(6):435-8. PubMed ID: 7478426
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.
    Repetto L, Miglietta L, Gardin G, Lanfranco C, Naso C, Merlini L, Giudici S, Venturino A, Campora E, Testore F.
    Breast Cancer Res Treat; 1994 Oct 15; 30(2):133-7. PubMed ID: 7949211
    [Abstract] [Full Text] [Related]

  • 20. The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancer.
    Hainsworth JD.
    Ann Oncol; 1993 Oct 15; 4 Suppl 2():37-40. PubMed ID: 7688982
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.